Bio-Gene Technology Limited
Research Bio-Gene Technology Limited (BGT.AX) on Bullrun: market cap AUD 5.69M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBGT.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 5.69M
- Financial periodFY2026
- Net income-AUD 2.33M
- Free cash flow-AUD 1.94M
Valuation Snapshot
latest market cap is AUD 5.69M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | n/a | -AUD 2.33M | -AUD 1.94M | n/a | n/a | AUD 1.94M | n/a | AUD 2.09M |
| FY2025 | n/a | -AUD 2.58M | -AUD 2.54M | n/a | -0.01 | AUD 1.14M | n/a | AUD 1.63M |
| FY2024 | n/a | -AUD 2.41M | -AUD 2.76M | n/a | -0.01 | AUD 2.21M | n/a | AUD 2.79M |
| FY2023 | AUD 595.08K | -AUD 3.10M | -AUD 3.28M | 100.0% | -0.02 | AUD 2.99M | n/a | AUD 3.22M |
| FY2022 | AUD 879.78K | n/a | n/a | 100.0% | -0.02 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | AUD 5.69M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Bio-Gene Technology Limited
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bio-Gene Technology Limited's market cap?
Bio-Gene Technology Limited's market capitalization is AUD 5.69M.
What does Bio-Gene Technology Limited do?
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone.